These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6618861)

  • 21. Morphological changes of erythrocytes in patients and carriers of Duchenne disease.
    Vasiljević ZM; Polić DD
    Acta Neurol Scand; 1983 Apr; 67(4):242-4. PubMed ID: 6858614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and identification of myoglobin in serum by immunoblotting. Effect of exercise on patients with Duchenne muscular dystrophy.
    Pöche H; Hopfenmüller W; Hoffmann M
    Clin Physiol Biochem; 1987; 5(2):103-11. PubMed ID: 3304774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 24. Radioimmunoassay of serum myoglobin in polymyositis and other conditions.
    Nishikai M; Reichlin M
    Arthritis Rheum; 1977; 20(8):1514-8. PubMed ID: 921823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma/serum myoglobin in prenatal diagnosis of Duchenne muscular dystrophy.
    Török O; Szabó M; Veress L; Papp Z
    Am J Med Genet; 1986 Oct; 25(2):237-8. PubMed ID: 3777021
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the value of radioimmunologic myoglobin determination in skeletal muscle disorders (author's transl)].
    Kiessling WR; Beckmann R
    Fortschr Neurol Psychiatr; 1981 Dec; 49(12):451-4. PubMed ID: 7343462
    [No Abstract]   [Full Text] [Related]  

  • 27. Radioimmunoassay of serum myoglobin in neuromuscular diseases.
    Askmark H; Osterman PO; Roxin LE; Venge P
    J Neurol Neurosurg Psychiatry; 1981 Jan; 44(1):68-72. PubMed ID: 7205308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte spectrofluorometric abnormalities in Duchenne patients and carriers. A new approach to carrier detection.
    Scarlato G; Meola G; Silani V; Manfredi L; Bottiroli G; Zanella A
    Acta Neurol Scand; 1979 May; 59(5):262-9. PubMed ID: 474067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myoglobinemia in children with progressive muscular dystrophy.
    Ando T; Shimizu T; Kato T; Ohsawa M; Fukuyama Y
    Clin Chim Acta; 1978 Apr; 85(1):17-22. PubMed ID: 647964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carrier detection of Duchenne and Becker muscular dystrophy using muscle dystrophin immunohistochemistry.
    Oliveira AS; Gabbai AA; Schmidt B; Kiyomoto BH; Lima JG; Minetti C; Bonilla E
    Arq Neuropsiquiatr; 1992 Dec; 50(4):478-85. PubMed ID: 1309152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of the direct capping technic in lymphocytes for the detection of women carrying the Duchenne type muscular dystrophy].
    Mayén DG; Carnevale A; Galindo A; Cid M; Berrón R; del Castillo V
    Rev Invest Clin; 1989; 41(3):241-5. PubMed ID: 2813998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid composition of erythrocytes. Findings in Duchenne's muscular dystrophy and myotonic atrophy.
    McLaughlin J; Engel WK
    Arch Neurol; 1979 Jun; 36(6):351-4. PubMed ID: 454232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology?
    Florence JM; Fox PT; Planer GJ; Brooke MH
    Neurology; 1985 May; 35(5):758-61. PubMed ID: 4039424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ineffectiveness of diltiazem in Duchenne muscular dystrophy: a placebo-controlled double-blind study].
    Toifl K; Presterl E; Graninger W
    Wien Klin Wochenschr; 1991; 103(8):232-5. PubMed ID: 1907056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative ELISA for platelet m-calpain: a phenotypic index for detection of carriers of Duchenne muscular dystrophy.
    Hussain T; Kumar DV; Sundaram C; Mohandas S; Anandaraj MP
    Clin Chim Acta; 1998 Jan; 269(1):13-20. PubMed ID: 9498100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myoglobin RIA in detecting carriers of Duchenne's muscular dystrophy.
    Sabria-Leal M; Gimeno-Leal JM; Paret-Masana A; Rey-Joly Barroso C
    Eur Neurol; 1986; 25(4):253-5. PubMed ID: 3720800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative EMG and histological carrier detection of Duchenne muscular dystrophy.
    Scarlato G; Valli G; Meola G; Carenini L
    J Neurol; 1977 Nov; 216(4):235-49. PubMed ID: 72807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum creatine kinase in the detection of Duchenne muscular dystrophy carriers: effects of season and multiple testing.
    Percy ME; Andrews DF; Thompson MW
    Muscle Nerve; 1982 Jan; 5(1):58-64. PubMed ID: 7057807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the carrier state in X-linked recessive (Duchenne) muscular dystrophy.
    Thomson WH; Sweetin JC; Hilditch TE
    Clin Chim Acta; 1975 Sep; 63(3):383-94. PubMed ID: 240524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.